Clinical Trial Update: Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL [Phase 1]

View source ↗

Summary

Phase 1 study of CAR-T cells targeting CD30 and CCR4 for relapsed/refractory CD30+ Hodgkin lymphoma and cutaneous T-cell lymphoma, with the trial currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Hodgkin Lymphoma
• Mycosis Fungoides
• Sezary Syndrome

Drugs mentioned

• CD30-CCR4 CAR-T cells (CD30- and CCR4-directed CAR-T cells)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Lymphoma, Immune System Diseases | Phase 1 | Status: ACTIVE_NOT_RECRUITING